Cargando…

Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan

High serum uric acid level (SUA) and chronic kidney disease (CKD) are risk factors for cardiovascular events (CVEs). However, their interactions as cardiovascular risk factors remain unknown. This subanalysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Sadayoshi, Naritomi, Hiroaki, Ogihara, Toshio, Shimada, Kazuyuki, Shimamoto, Kazuaki, Tanaka, Heizo, Yoshiike, Nobuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419971/ https://www.ncbi.nlm.nih.gov/pubmed/22573200 http://dx.doi.org/10.1038/hr.2012.59

Ejemplares similares

Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trial
por: Ogihara, Toshio, et al.
Publicado: (2015)

Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability
por: Saruta, Takao, et al.
Publicado: (2015)

Association of Human Cholesteryl Ester Transfer Protein-TaqI Polymorphisms with Serum HDL Cholesterol Levels in a Normolipemic Japanese Rural Population
por: Chen, Jianguo, et al.
Publicado: (2007)

Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
por: Kjeldsen, S E, et al.
Publicado: (2010)

Are the Associations between Life-style Related Factors and Plasma Total Homocysteine Concentration Different According to Polymorphism of 5,10-Methylenetetrahydrofolate Reductase Gene (C677T MTHFR)?: - A Cross-sectional Study in a Japanese Rural Population -
por: Lwin, Htay, et al.
Publicado: (2007)

Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria
por: Bryant, Charlotte E., et al.
Publicado: (2021)

Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial(1)
por: Ogihara, Toshio, et al.
Publicado: (2014)

Genetics of Hypertension and Cardiovascular Disease
por: Katsuya, Tomohiro, et al.
Publicado: (2011)

A randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study
por: Ueda, Shinichiro, et al.
Publicado: (2014)

Urinary stones resembling uric acid stones
por: Tanemoto, Masayuki, et al.
Publicado: (2010)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura, Makiko, et al.
Publicado: (2014)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats
por: Guo, Qi, et al.
Publicado: (2012)

Sex-related differences for uric acid in the prediction of cardiovascular events in essential hypertension. A population prospective study
por: Perticone, Maria, et al.
Publicado: (2023)

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease
por: Furuhashi, Masato, et al.
Publicado: (2011)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
por: Park, C. G., et al.
Publicado: (2001)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Bharati, Sandesh Madhukar, et al.
Publicado: (2016)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Rakesh, K. B., et al.
Publicado: (2016)

The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia
por: Wu, Liting, et al.
Publicado: (2021)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
por: Akbar Nekooeian, Ali, et al.
Publicado: (2021)

Does Losartan reduce the severity of COVID-19 in hypertensive patients?
por: Mirjalili, Mohammadreza, et al.
Publicado: (2022)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Prospective Study of Serum Uric Acid Levels and First Stroke Events in Chinese Adults With Hypertension
por: Hu, Feng, et al.
Publicado: (2021)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
por: Granström, Ola, et al.
Publicado: (2012)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
por: Mulinari-Santos, Gabriel, et al.
Publicado: (2019)

Correlation analysis of low-level serum uric acid and cardiovascular events in patients on peritoneal dialysis
por: Li, Qiuyue, et al.
Publicado: (2021)

Observation of the Serum Uric Acid in Essential Hypertension
por: Kim, Yeon Ho, et al.
Publicado: (1986)

Serum uric acid and the incidence of CKD and hypertension
por: Kuriyama, Satoru, et al.
Publicado: (2015)

Increased cardiovascular risk of treated white coat and masked hypertension in patients with diabetes and chronic kidney disease: the HONEST Study
por: Kushiro, Toshio, et al.
Publicado: (2017)

Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values
por: Casiglia, Edoardo, et al.
Publicado: (2023)

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013)

Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome
por: Masajtis-Zagajewska, Anna, et al.
Publicado: (2021)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)

Changes of Gene Expressions in Spontaneously Hypertensive Rat Model After Losartan Treatment
por: Cha, Ji Hei, et al.
Publicado: (2012)

Losartan Improved Antioxidant Defense, Renal Function and Structure of Postischemic Hypertensive Kidney
por: Ivanov, Milan, et al.
Publicado: (2014)

Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70
por: Costantino, Valeria Victoria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bgg488s33qc7t57eqhlctc1lmg